article thumbnail

Utilization of Treatment for Chlamydia and Gonorrhea in the Primary Care Setting Using the American Family Cohort [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Since untreated cases can have severe health consequences, non-adherence to the Centers for Disease Control and Prevention Sexually Transmitted Disease Treatment guidelines (CDC) remains a concern. Study Design and Analysis: A retrospective cohort from 2018-2022. treatment rates, respectively.

article thumbnail

Implementation of Combined PCBH and CCBHC Models: Key Considerations

Integrated Care News by CFHA

A recent inquiry within the CFHA community sought recommendations on implementing the Primary Care Behavioral Health (P CBH) model at a Federally Qualified Health Center (FQHC) that had received CCBHC Demonstration. Below are a few key considerations for making this type of integration work: 1. Culture, culture, culture! Dobmeyer, A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Treatment of Chlamydia and Gonorrhea in Primary Care and Its Patient-Level Variation: An American Family Cohort Study [Original Research]

Annals of Family Medicine

Nonadherence to the Centers for Disease Control and Prevention treatment guidelines remains a concern. METHODS We used electronic health records from the PRIME registry to identify patients with diagnosis codes or positive test results for chlamydia and/or gonorrhea from 2018 to 2022.

article thumbnail

How Mental Health & SUD Bias Impact ED Physical Care

Physician's Weekly

Mental health and SUD bias impact the quality of ED care that patients with these conditions receive for physical health concerns, according to research. What the Patients Said According to the study, three key themes emerged: Negative encounters dominated. Isbell, PhD , of the University of Massachusetts Amherst, and colleagues.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

Insurance companies have promised changes like these before, in 2018 and 2023, but many didn’t follow through, Dr. Mehmet Oz , head of the Centers for Medicare & Medicaid Services (CMS), said. Insurers must provide clearer explanations when care is denied and explain how patients can appeal.

52
article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

The California-based firm, Second Sight , the German company, Retina Implant AG, and the French venture, Pixium Vision were the forerunners of the field, developing implantable visual prosthetics to restore vision to patients who are blind as a result of the rare condition of retinitis pigmentosa.

article thumbnail

FDA Medical Device Ban Overturned For the First Time

FDA Law Blog

In March 2020, FDA issued a final rule that banned the use of Graduated Electronic Decelerators (GEDs) to treat patients with severe self-injurious and aggressive behaviors (SIB/AB), but did not restrict the use of these same devices for other purposes, like smoking cessation. Circuit Court of Appeals to overturn the ban.

Medical 52